Who owns Elicio Therapeutics Inc Com?
- Ticker: ELTX
- CUSIP Number: 28657f103
Tip: Access positions for across all investors
Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Elicio Therapeutics stock
Who bought or sold Elicio Therapeutics Inc Com this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Knoll Capital Management | 631k | $6.7M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 519k | $5.5M | 100% | Mar 2026 |
|
| Susquehanna International | 374k | $4.0M | 484% | Mar 2026 |
|
| Balyasny Asset Management | 245k | $2.6M | 76% | Mar 2026 |
|
| Geode Capital Management | 135k | $1.4M | 2% | Mar 2026 |
|
| Renaissance Technologies | 122k | $1.3M | 333% | Mar 2026 |
|
| Jane Street | 116k | $1.2M | 100% | Mar 2026 |
|
| Millennium Management | 93k | $992k | 100% | Mar 2026 |
|
| Citadel Advisors | 78k | $835k | 46% | Mar 2026 |
|
| Marshall Wace | 75k | $797k | -36% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 69k | $740k | 100% | Mar 2026 |
|
| Northern Trust | 60k | $639k | 13% | Mar 2026 |
|
| Goldman Sachs Group | 58k | $618k | 100% | Mar 2026 |
|
| 683 Capital Management | 56k | $603k | 0% | Mar 2026 |
|
| State Street Corporation | 51k | $541k | 9% | Mar 2026 |
|
| BlackRock | 51k | $541k | 12% | Mar 2026 |
|
| UBS Group | 34k | $361k | 5% | Mar 2026 |
|
| Morgan Stanley | 32k | $346k | 123% | Mar 2026 |
|
| Iridian Asset Management | 30k | $321k | 100% | Mar 2026 |
|
| CM Management | 25k | $267k | 0% | Mar 2026 |
|
| Hrt Financial | 22k | $231k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 20k | $216k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 17k | $186k | 100% | Mar 2026 |
|
| Quadrature Capital | 17k | $181k | -1% | Mar 2026 |
|
| Bank of America Corporation | 15k | $164k | 100% | Mar 2026 |
|
| Meyer Handelman | 14k | $149k | 0% | Mar 2026 |
|
| Kingswood Wealth Advisors | 14k | $148k | 100% | Mar 2026 |
|
| XTX Topco | 14k | $147k | 100% | Mar 2026 |
|
| Engineers Gate Manager | 13k | $141k | 100% | Mar 2026 |
|
| Qube Research & Technologies | 13k | $133k | -38% | Mar 2026 |
|
| Sio Capital Management | 12k | $125k | -96% | Mar 2026 |
|
| Cresset Asset Management | 11k | $122k | 100% | Mar 2026 |
|
| HighTower Advisors | 11k | $119k | 0% | Mar 2026 |
|
| Raymond James Financial | 11k | $119k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 11k | $114k | -54% | Mar 2026 |
|
| HB Wealth Management | 11k | $112k | 100% | Mar 2026 |
|
| Summit Financial | 10k | $107k | 0% | Mar 2026 |
|
| Wiley Bros.-aintree Capital | 10k | $107k | 0% | Mar 2026 |
|
| Moody Lynn & Co/ | 10k | $107k | 0% | Mar 2026 |
|
| Mayflower Financial Advisors | 10k | $39k | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 6.3k | $68k | 12% | Mar 2026 |
|
| Vanguard Global Advisers | 4.4k | $47k | 100% | Mar 2026 |
|
| EFG International | 2.2k | $24k | 100% | Mar 2026 |
|
| Steward Partners Investment Advisory | 2.0k | $22k | 30% | Mar 2026 |
|
| Farther Finance Advisors | 947.00 | $3.7k | 31% | Jun 2026 |
|
| SBI Securities | 82.00 | $876.998200 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 23.00 | $0 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $32.000100 | 100% | Mar 2026 |
|
| Tower Research Capital | 1.00 | $11.000000 | 100% | Mar 2026 |
|
Who sold out of Elicio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Dec 2025 | 17k | $133k |
| Occudo Quantitative Strategies | Dec 2025 | 16k | $126k |
| Leucadia National Corporation | Dec 2025 | 12k | $95k |
| Point72 Asset Management | Dec 2025 | 12k | $93k |
| Group One Trading | Dec 2025 | 323.00 | $2.6k |
| Wells Fargo & Company | Dec 2025 | 200.00 | $1.6k |
| Fortitude Family Office | Dec 2025 | 93.00 | $740.001000 |